STOCK TITAN

Exact Sciences to participate in November investor conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Exact Sciences Corp. (Nasdaq: EXAS) announced that company management will participate in several upcoming conferences and invited investors to participate by webcast. The conferences include Stifel Healthcare Conference, Jefferies London Healthcare Conference, Piper Sandler 35th Annual Healthcare Conference, and Evercore ISI HealthCONx Conference. The webcasts can be accessed on the company's website.
Positive
  • None.
Negative
  • None.

MADISON, Wis., Nov. 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • Stifel Healthcare Conference, New York
    Fireside chat on Tuesday, November 14, 2023 at 10:20 a.m. ET

  • Jefferies London Healthcare Conference, London
    Fireside chat on Wednesday, November 15, 2023 at 9:30 a.m. ET

  • Piper Sandler 35th Annual Healthcare Conference, New York
    Fireside chat on Tuesday, November 28, 2023 at 2:00 p.m. ET

  • Evercore ISI HealthCONx Conference, Miami
    Fireside chat on Wednesday, November 29, 2023 at 12:30 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-november-investor-conferences-301973859.html

SOURCE Exact Sciences Corporation

FAQ

What is the company name mentioned in the press release?

The company mentioned in the press release is Exact Sciences Corp.

What is the stock symbol for Exact Sciences Corp.?

The stock symbol for Exact Sciences Corp. is EXAS.

What conferences will the company management participate in?

The company management will participate in the Stifel Healthcare Conference, Jefferies London Healthcare Conference, Piper Sandler 35th Annual Healthcare Conference, and Evercore ISI HealthCONx Conference.

How can investors access the webcasts?

Investors can access the webcasts in the investor relations section of Exact Sciences' website at www.exactsciences.com.

Exact Sciences Corporation

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

9.84B
179.56M
1.01%
89.38%
3.49%
Diagnostic Imaging Centers
Health Care and Social Assistance
Link
United States of America
MADISON

About EXAS

exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences'​ noninvasive colon cancer screening test, visit cologuardtest.com